TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

34 hedge funds and large institutions have $3.32M invested in Theriva Biologics in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$126K
2
+$88K
3
+$43.5K
4
UBS Group
UBS Group
Switzerland
+$24K
5
Citadel Advisors
Citadel Advisors
Florida
+$15.2K

Top Sellers

1
-$26.4K
2
-$462
3
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$925K
2
$863K
3
$448K
4
$217K
5
$126K
6
$113K
7
$98K
8
$94K
9
$88K
10
$59K
11
$58K
12
$53K
13
$34K
14
$24K
15
$20K
16
$11K
17
$11K
18
$10K
19
$10K
20
$9K
21
$9K
22
$9K
23
$9K
24
$6K
25
$6K
1
2